2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Lung Neoplasms
3
Neoplasms
2
Motor Activity
2
Breast Neoplasms
2
Anxiety Disorders
2
Stress Disorders, Post-Traumatic
1
Social Stigma
1
Noonan Syndrome
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Legius syndrome
1
Hematologic Neoplasms
1
Genetic Diseases, Inborn
1
Generalized Anxiety Disorder
1
Fatigue
1
Depression
1
Costello Syndrome
1
Chronic Pain
1
Cardiofaciocutaneous syndrome
1
Breast Cancer With Chronic Lymphedema
1
Breast Cancer Female
1
Interventions
pembrolizumab
185
Gemcitabine
170
Paclitaxel
152
Carboplatin
137
Bevacizumab
128
Surveys and Questionnaires
118
Cisplatin
115
Docetaxel
114
Blood Specimen Collection
110
Cyclophosphamide
109
Exercise
108
Nivolumab
98
Fluorouracil
90
Capecitabine
86
Dexamethasone
81
Radiotherapy
80
Irinotecan
74
Standard of Care
69
Pemetrexed
68
Oxaliplatin
68
Leucovorin
64
Drug Therapy
64
Cetuximab
60
Erlotinib Hydrochloride
56
Sorafenib
53
atezolizumab
52
Ipilimumab
51
Doxorubicin
50
trametinib
47
Interviews as Topic
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms
×
Waiting Lists
×
Clear all
NCT04414436
2021-08-25
GYNEA
Haukeland University Hospital
Phase NA
Unknown
100 enrolled
NCT02992405
2019-02-07
FOCUS
Cedars-Sinai Medical Center
Phase NA
Completed
32 enrolled